ReviewOncoTargets and therapy2014

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors.

Elizabeth C Smyth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.